FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
For FDA Voices older than 2023, please view the archived page.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Lessons Learned from our Roundtable with Rare Disease Advocates
Recently FDA leadership held a roundtable discussion with 15 dedicated rare disease leaders.
Ensuring Quality and Access: FDA’s Approach to Generic Drug Oversight
FDA continues to prioritize the speed and efficiency with which generic drugs are regulated, balancing the need for minimizing risk and ensuring access.
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|